| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nektar Therapeutics (NKTR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. NKTR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 75.9K | $5.14M | - | |
| Other | 21.6K | $1.46M | - | |
| Other | 15.4K | $1.04M | -5,538 | |
| Dir | 8.0K | $541.4K | - | |
| Dir | 8.0K | $541.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2020 | Robin Howard W58 | President &CEO | Sell | 8,448 | $22.35 | $188,812.80 | -2.1% | |
| Feb 18, 2020 | Labrucherie Gil M84 | SVP, COO &CFO | Sell | 5,938 | $22.35 | $132,714.30 | -2.3% | |
| Feb 12, 2020 | Chess Robert84 | Director | Sale+OE | 8,000 | $23.50 | $187,999.60 | -1.4% | |
| Feb 6, 2020 | Thomsen Jillian B.86 | SVP &Chief Accounting Officer | Sale+OE | 37,500 | $22.78 | $854,250.00 | -17.6% | |
| Nov 18, 2019 | Zalevsky Jonathan63 | Chief R&D Officer | Sell | 3,960 | $17.97 | $71,161.20 | -1.3% | |
| Nov 18, 2019 | Thomsen Jillian B.86 | SVP &Chief Accounting Officer | Sell | 2,713 | $17.97 | $48,752.61 | -1.7% | |
| Nov 18, 2019 | Robin Howard W58 | President &CEO | Sell | 13,556 | $17.97 | $243,601.32 | -4.3% | |
| Nov 18, 2019 | Labrucherie Gil M84 | SVP, COO &CFO | Sell | 8,863 | $17.97 | $159,268.11 | -3.9% | |
| Nov 13, 2019 | Labrucherie Gil M84 | SVP, COO &CFO | Sale+OE | 25,000 | $19.79 | $494,750.00 | -9.9% | |
| Oct 17, 2019 | Robin Howard W58 | President &CEO | Sale+OE | 100,000 | $17.37 | $1,737,090.31 | -7.3% |